Angiotensin II Type 1 Receptor BlockersTetrazolesAngiotensin Receptor AntagonistsBenzimidazolesAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersAntihypertensive AgentsLosartanAngiotensin II Type 2 Receptor BlockersRenin-Angiotensin SystemBenzoatesValineReceptor, Angiotensin, Type 1HypertensionImidazolesBiphenyl CompoundsAdrenergic beta-AntagonistsAngiotensin IIAmlodipineBlood PressurePotassium Channel BlockersDrug Therapy, CombinationDiureticsReceptors, AngiotensinMineralocorticoid Receptor AntagonistsHydrochlorothiazideAzetidinecarboxylic AcidFumaratesRats, Sprague-DawleySodium Channel BlockersSpironolactoneDose-Response Relationship, DrugDihydropyridinesThiazepinesReceptor, Angiotensin, Type 2ProteinuriaRats, WistarHeart FailureDiabetic NephropathiesTreatment OutcomeKidneyLisinoprilReninPheniramineNifedipineAcrylatesHyperkalemiaAdrenergic AntagonistsCardiovascular AgentsCalciumAlbuminuriaKidney DiseasesRamiprilTime FactorsAmidesEnalaprilDisease Models, AnimalPyridinesReceptor, Endothelin ARandomized Controlled Trials as TopicReceptors, EndothelinAdrenergic beta-1 Receptor AntagonistsAdrenergic alpha-AntagonistsPatch-Clamp TechniquesMyocardial InfarctionAtenololEndothelin-1Angiotensin IRats, Inbred SHRCells, CulturedDouble-Blind MethodHydroxymethylglutaryl-CoA Reductase InhibitorsExcitatory Amino Acid AntagonistsVasoconstrictor AgentsDiabetes Mellitus, Type 2AldosteronePropanolaminesThiophenesHemodynamicsMembrane PotentialsOxidative StressMetoprololVasodilationMyocardiumGlomerular Filtration RateHeart RatePeptidyl-Dipeptidase AHydralazineRats, Inbred DahlMacrocyclic CompoundsEnzyme InhibitorsKidney Failure, ChronicBenzazepinesVentricular RemodelingOxadiazolesElectrophysiologyPotassiumVerapamilDiltiazemAngiotensins